title: Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study.
authors: Guido
authors: G
authors: Parodi
authors: Ioanna
authors: I
authors: Xanthopoulou
authors: Benedetta
authors: B
authors: Bellandi
authors: Vassilios
authors: V
authors: Gkizas
authors: Renato
authors: R
authors: Valenti
authors: Stavros
authors: S
authors: Karanikas
authors: Angela
authors: A
authors: Migliorini
authors: Christos
authors: C
authors: Angelidis
authors: Rosanna
authors: R
authors: Abbate
authors: Sotirios
authors: S
authors: Patsilinakos
authors: Giorgio J
authors: GJ
authors: Baldereschi
authors: Rossella
authors: R
authors: Marcucci
authors: Gian Franco
authors: GF
authors: Gensini
authors: David
authors: D
authors: Antoniucci
authors: Dimitrios
authors: D
authors: Alexopoulos
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002626:Chemistry, Pharmaceutical; D006801:Humans; D038622:Internationality; D007441:Intubation, Gastrointestinal / Q000379:methods; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D013607:Tablets; D000077486:Ticagrelor
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D013607:Tablets; D000077486:Ticagrelor; D000241:Adenosine